ARTV Artiva Biotherapeutics, Inc.: Company Short-Term Debts

Symbol and logo of brand Artiva (ARTV)

Artiva Biotherapeutics, Inc. (ARTV) develops allogeneic NK therapies that enable the immediate treatment of leukemia patients. The company leverages big pharma support and high loyalty among clinical trial participants. Its product portfolio is diversified through partnerships that mitigate R&D financial risks. The short-term debt chart confirms these data, and 0.00 captures the current value of the indicator, demonstrating the level of credit leverage.

ARTV artivabio.com Company Short-Term Loans and Borrowings (07/20/2024 - 11/01/2026)

ARTV (Artiva Biotherapeutics Inc.): analytical breakdowns and indicator data

- stock price and consensus target price:
Stock Price Artiva|ARTV - Consensus Target
- company stock capitalization data:
Market Capitalization Artiva Biotherapeutics, Inc.|ARTV - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share Artiva Biotherapeutics|ARTV - Accounting Value of Company|Market Cap to Net Assets Ratio artivabio.com|ARTV - Aggregate Asset Value
- debt and liquidity details:
Total Debt to Capital Artiva Biotherapeutics, Inc.|ARTV - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Artiva|ARTV - Company Aggregate Debts|Debt to Book Capitalization Ratio Artiva Biotherapeutics, Inc.|ARTV - Company Long-Term Loans and Borrowings|Company Short-Term Debts Artiva Biotherapeutics|Quick Ratio artivabio.com
- earnings and multiples data:
ARTV - Net Profit
Analysis of all company metrics:ARTV - artivabio.com
Manufactured products of Artiva Biotherapeutics, Inc.

The market views Artiva Biotherapeutics, Inc. (ARTV) as a promising asset due to the uniqueness of its NK-cell therapy and its potential for pricing power. An analysis of short-term balance sheet liabilities allows for an assessment of total loans maturing within one year, which is critical for controlling the liquidity of this biotech startup. The dynamics of these liabilities reveal a risk of cash flow gaps, determining the stability of this high-risk security.

Competing companies

BeiGene - Company Short-Term Debts|Halozyme Therapeutics, Inc. (HALO) - Company Current Liabilities|RVMD: Company Short-Term Debts|Short-Term Debt Ascentage Pharma Corp (AAPG)|Company Short-Term Debt CG Oncology, Inc.|URGN: Company Short-Term Loans and Borrowings|Company Current Liabilities BCAX (Bicara Therapeutics)|PSNL (Personalis Inc) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ERAS (Erasca Corp)|DCTH - Company Current Liabilities|YMAB: Company Current Liabilities|AURA - Company Short-Term Debts|candeltx.com (CADL) - Company Short-Term Debt|Accuray Inc - Company Short-Term Loans and Borrowings|SLS (SELLAS Life Sciences Group, Inc.) - Company Short-Term Debts|Short-Term Debt Actuate Therapeutics Inc ACTU|Company Short-Term Debts CTOR|Company Short-Term Debts tuhurabio.com (HURA)|Company Short-Term Debt Protara Therapeutics, Inc. TARA|Company Short-Term Loans and Borrowings FATE|WHWK: Company Current Liabilities|TScan Therapeutics - Amount of Current Liabilities|CSBR: Company Short-Term Debts|XBIT - Short-Term Debt Volume|Company Current Liabilities CVM|Company Short-Term Debt OSTX|Company Short-Term Debts RADX|Company Short-Term Debts adlainortye.com (ANL)|Veru Inc. - Company Current Liabilities|Company Short-Term Loans and Borrowings TPST|Xilio - Company Short-Term Debts|RENB: Company Short-Term Debt|MURA: Company Short-Term Debts|KAPA - Short-Term Debt Volume|Company Short-Term Debt OnKure Therapeutics, Inc.|Short-Term Debt CytoMed GDTC|Company Current Liabilities CRIS (Curis, Inc.)|Amount of Current Liabilities APLM|Company Short-Term Debts THAR (Tharimmune Corp)|Company Short-Term Loans and Borrowings ADVB|Genprex, Inc. - Company Short-Term Debts|Short-Term Debt Calidi Biotherapeutics|Sunshine Biopharma (SBFM) - Company Short-Term Debt|Xenetic Biosciences, Inc. - Company Short-Term Loans and Borrowings|SLRX (Salarius) - Company Short-Term Debts|Company Short-Term Debts Kitov Pharma|Company Short-Term Debt American Oncology Network (AONC)|BGNE: Current Liabilities|Company Short-Term Debts CKPT (Checkpoint Therapeutics, Inc.)|Elevation Oncology Inc. (ELEV) - Short-Term Debt|ICAD: Company Current Liabilities|IKNA - Company Short-Term Debts|NTBL (Notable Labs, Ltd.) - Company Current Liabilities|VIRX: Amount of Current Liabilities|MOR (MorphoSys) - Company Short-Term Debts|NAYA Biosciences Inc (NAYA) - Short-Term Debt Volume|Company Short-Term Debts AAPGV